Clinical Trial

Efficacy of the Extracorporeal Shock Wave Therapy in Athletes With Patellar Tendinopathy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 31, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to investigate the effectiveness of extracorporeal shock wave therapy (ESWT) in addition to eccentric exercise on the clinical outcomes of PT in the treatment of athletes with patellar tendinopathy (PT). Participants will be randomly divided into two groups. The intervention group will receive focus ESWT 3 times a week in addition to 6 weeks of exercise. The control group will be given 6 weeks of exercise. Evaluations will be made at the 3rd and 6th weeks, and at the 3rd, 6th and 12th months. Patient evaluation will begin with obtaining sociodemographic information. Patients' pain level will be assessed using visual analog scale (VAS), tendon pain and function VISA-P, functional capacity; The patients will be assessed with the maximal vertical jump test (MDS), single leg jump distance test (SLHD), single leg squat test (STS) on the incline board, pain catastrophe with the pain catastrophe scale (PCS), kinesiophobia with the Tampa Kinesiophobia Scale (TKS), quality of life short form-12 (SF-12) and physical activity level with the Tegner Activity Scale (TAS).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-23.
Status change: Not Yet Recruiting → Recruiting 2025-01-29
Trial Details
NCT Number NCT06705881
Lead Sponsor Ahi Evran University Education and Research Hospital
Conditions Patellar Tendinopathy, Patellar Tendon Pain
Enrollment 32 participants
Start Date 2024-12-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-31